These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. Snyder PJ, Muzyka R, Johnson J, Utiger RD. J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992 [Abstract] [Full Text] [Related]
3. Gonadotroph adenoma with secondary hypersecretion of testosterone. Chamoun R, Layfield L, Couldwell WT. World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183 [Abstract] [Full Text] [Related]
4. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist. Daneshdoost L, Pavlou SN, Molitch ME, Gennarelli TA, Savino PJ, Sergott RC, Bosley TM, River JE, Vale WW, Snyder PJ. J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048 [Abstract] [Full Text] [Related]
5. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. Klibanski A, Jameson JL, Biller BM, Crowley WF, Zervas NT, Rivier J, Vale WW, Bikkal H. J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852 [Abstract] [Full Text] [Related]
6. LH- and FSH-secreting pituitary adenoma in a postmenopausal woman. Hattori N, Ishihara T, Moridera K, Ikekubo K, Hino M, Saiki Y, Kurahachi H. Endocrinol Jpn; 1991 Aug; 38(4):393-6. PubMed ID: 1802680 [Abstract] [Full Text] [Related]
7. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery. Harris RI, Schatz NJ, Gennarelli T, Savino PJ, Cobbs WH, Snyder PJ. J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924 [Abstract] [Full Text] [Related]
8. Follicle-stimulating hormone-secreting pituitary adenomas. Beckers A, Stevenaert A, Mashiter K, Hennen G. J Clin Endocrinol Metab; 1985 Sep; 61(3):525-8. PubMed ID: 2991325 [Abstract] [Full Text] [Related]
9. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor. Roman SH, Goldstein M, Kourides IA, Comite F, Bardin CW, Krieger DT. J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331 [Abstract] [Full Text] [Related]
10. Hypersecretion of LH and FSH by a pituitary adenoma. Snyder PJ, Sterling FH. J Clin Endocrinol Metab; 1976 Mar; 42(3):544-50. PubMed ID: 767353 [Abstract] [Full Text] [Related]
11. FSH and LH secreting pituitary adenoma. Demura R, Kubo O, Demura H, Shizume K. J Clin Endocrinol Metab; 1977 Oct; 45(4):653-7. PubMed ID: 334787 [Abstract] [Full Text] [Related]
12. The basal levels of serum prolactin (PRL), luteinizine hormone (LH), follicle stimulating hormone (FSH), testosterone, thyroxine (T4), and cortisol in patients with pituitary mass: detection and evaluation. Namking M, Pavasuthipaisit K, Lerthamtewe W, Bunyaratavej S, Himathongkam T. J Med Assoc Thai; 1981 Feb; 64(2):76-85. PubMed ID: 6785372 [No Abstract] [Full Text] [Related]
13. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine. Berezin M, Olchovsky D, Pines A, Tadmor R, Lunenfeld B. J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289 [Abstract] [Full Text] [Related]
14. Return of gonadal function in men with prolactin-secreting pituitary tumors. Murray FT, Cameron DF, Ketchum C. J Clin Endocrinol Metab; 1984 Jul; 59(1):79-85. PubMed ID: 6427273 [Abstract] [Full Text] [Related]
15. An FSH-producing pituitary tumor in a patient with hypogonadism. Woolf PD, Schenk EA. J Clin Endocrinol Metab; 1974 Apr; 38(4):561-8. PubMed ID: 4362394 [No Abstract] [Full Text] [Related]
16. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. Nobels FR, Kwekkeboom DJ, Coopmans W, Hoekstra R, De Herder WW, Bouillon R, Lamberts SW. J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365 [Abstract] [Full Text] [Related]
17. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. Arafah BM. J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521 [Abstract] [Full Text] [Related]
18. Precocious puberty in a boy with a PRL-, LH- and FSH-secreting pituitary tumour: hormonal and immunocytochemical studies. Ambrosi B, Bassetti M, Ferrario R, Medri G, Giannattasio G, Faglia G. Acta Endocrinol (Copenh); 1990 May; 122(5):569-76. PubMed ID: 2112813 [Abstract] [Full Text] [Related]
19. Recognition of gonadotroph adenomas in women. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ. N Engl J Med; 1991 Feb 28; 324(9):589-94. PubMed ID: 1899470 [Abstract] [Full Text] [Related]
20. Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepuberal boys, and hypopituitary patients. Bardin CW, Ross GT, Rifkind AB, Cargille CM, Lipsett MB. J Clin Invest; 1969 Nov 28; 48(11):2046-56. PubMed ID: 4390462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]